Friday, November 22nd, 2024

Uchi Technologies: Steady Dividends Amid Currency Challenges

Date of Report: October 25, 2024
Broker: CGS International


Overview

Uchi Technologies Berhad is a Malaysian company specializing in the design, manufacturing, and sale of electronic control modules. These modules are primarily used in automated coffee machines, biosensors, and other industrial and consumer electronic products.

Stock Performance

Uchi Technologies is currently rated as “Maintain Add” by CGS International, though its target price (TP) has been revised downward to RM4.30. Despite facing near-term challenges, the company remains a solid investment, supported by its attractive dividend yields.

Recent Developments

In a recent meeting with Uchi Technologies’ management, discussions centered around anticipated near-term weakness in the second half of 2024. This is attributed to softer sales in US dollars (USD) and adverse currency exchange rates, particularly the strengthening of the Malaysian ringgit (MYR) against the USD.

Financial Adjustments

CGS International has adjusted its earnings per share (EPS) forecasts for Uchi Technologies, lowering the expected figures for FY24-FY26 by 9-12%. These adjustments account for the reduced revenue growth rate in USD and the impact of the stronger ringgit. Despite this, the company’s fundamentals remain robust.

Dividend Prospects

One of the key highlights for Uchi Technologies is its strong dividend yield, which is projected to exceed 6% for FY24 through FY26. This makes the stock an attractive option for investors seeking stable income, even amid challenging market conditions.

Analyst Commentary

While there are near-term headwinds for Uchi Technologies due to currency factors, the company’s solid dividend payouts and stable business model offer investors a level of confidence. The “Maintain Add” rating reflects the view that, despite a lower target price, the stock still holds value for long-term investors, particularly those interested in income generation.


Source: CGS International Trendspotter, October 25, 2024.

KPJ Healthcare (KPJ MK) – on track to achieve a 20% year-on-year growth in medical tourism revenue for 2024, with the Malaysia Healthcare Travel Council targeting a revenue of RM2.4 billion for the year.

KPJ Healthcare (KPJ MK) – Update Share Price: RM2.07 | Target Price: RM1.90 | Rating: HOLD Company Overview KPJ Healthcare is Malaysia’s largest private hospital operator. The company is undergoing a transformation programme aimed...

Far East Hospitality: Set to Thrive with China’s Economic Recovery and Increased Tourism

Date of Report October 1, 2024 Broker Name UOB Kay Hian Company Overview Far East Hospitality Trust is a Singapore-based hospitality real estate investment trust (REIT) that focuses on the ownership and management of...

Top Glove Corporation: Navigating Recovery with Strategic Resilience

Date: October 22, 2024Broker: CGS International Company Overview Top Glove Corporation is the world’s largest manufacturer of gloves, headquartered in Malaysia. The company produces a wide range of glove products, including latex, nitrile, and...